TAVR in the Different Types of Aortic Stenosis

Aortic stenosis (AS) is classified according to gradient into high flow and high gradient (D1), low flow-low gradient with reduced ejection fraction (D2), and paradoxical low flow-low gradient with conserved ejection fraction (D3).

Nuevas guías de valvulopatías con actualizaciones clave en TAVI e insuficiencia mitral

D3 AS is characterized by ≥50% ejection fraction, but with systolic volume index ≤35 ml/min.

Post TAVR evolution of D2 and D3 AS, as regards quality of life, has not been thoroughly looked into by the existing studies. 

This study looked at 634 patients, 328 presenting D1, 76 with D2 and 230 with D3 AS.

Mean age was 77, 60% were men and STS was 6.6%, with no significant differences in comorbidities, except in those with D2 AS, who presented higher incidence of cardiac failure, functional class IV, atrial fibrillation, definite pacemaker implantation, higher need of cardio-defibrillator prior TAVR and lower ejection fraction. 

At 30 days, those with D1 AS showed higher mortality (2.5% vs. 0% vs. 0%, p=0.03 for D1, D2 and D3 AS respectively), with no differences in stroke, major bleeding, or dialysis need. The need for definite pacemaker implantation was higher among D2 AS patients.

Read also: Physiologically Significant Obstructions in the Left Main Coronary Artery: Revascularizing vs. Deferring.

After one year followup, there were no significant differences in mortality, stroke, MI, major bleeding, need for pacemaker implantation or readmission. All 3 groups experienced improved functional class and quality of life. D2 AS patients also showed improved ejection fraction. 

Conclusion

Patients with D2 AS experienced significant improvement in ejection fraction and quality of life at 30 days and one year. The need for pacemaker implantation after TAVR was higher than in the other subtypes, while stroke and mortality were lower than expected, which supports the use of TAVR in this high risk group. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Transcatheter Aortic Valve Replacement Improves Quality of Life and Ventricular Function With Low-Flow/Low-Gradient Aortic Stenosis

Reference: Kelley N. Benck , et al. JSCAIhttps://doi.org/10.1016/j.jscai.2023.101266. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....